Hoping that other women did not have to go through what she went through, in 1993 she co-founded the Alamo Breast Cancer Foundation (ABCF), a grassroots organization that helps patient advocates become educated on the disease – ultimately leading to more informed treatment decisions.
Breast cancer survivor shares what happened when she found a new lump and got a genetic test result for PALB2.
Halle Moore, M.D., physician at Department of Solid Tumor Oncology at Cleveland Clinic Taussig Cancer Institute, discusses fertility preservation in women with breast cancer.
“It was frustrating always being the youngest one in the waiting room, combined with the fact that there is just not a lot of data on this population. So, we are forced to make decisions in the absence of hard data. It’s frustrating to know that we’re the neglected cohort of the disease,” Petrides said.
Losing even a moderate amount of extra weight significantly reduces the risk of breast cancer for postmenopausal women, a researcher reports.
Researchers find that women with postmenopausal hormone receptor (HR)-positive breast cancer may undergo shorter treatments of Arimidex, which may in turn cause less bone fractures.
A phase 3 clinical trial pitted a nine-week treatment of adjuvant Herceptin against the regimen of a full year of treatment for patients with HER2-positive breast cancer. Results show that the standard treatment of one year is still optimal.
To address compliance issues associated with treatment using aromatase inhibitors, researchers show that acupuncture effectively eases joint pain, a side effect from hormone therapy.
A reveiw of five clinical trial findings suggests that gonadotropin-releasing hormone analog has the potential to preserve ovarian function and fertility in premenopausal breast cancer patients.
New research demonstrates that a CDK4/6 inhibitor, used in combination with standard endocrine therapy with temporary ovarian suppression significantly improves progression-free survival in younger patients who currently have few treatment options.
The combination of Keytruda (pembrolizumab) and Herceptin (trastuzumab) showed promise for the treatment of women with Herceptin-resistant, PD-L1–positive, HER2-positive breast cancer.
A stud presented at SABCS shows that IMMU-132, an antibody-drug conjugate, improves outcomes in women with heavily pretreated metastatic triple-negative breast cancer.
The combination use of Herceptin plus standard adjuvant chemotherapy does not improve outcomes in women with HER2-low breast cancer.
For women with early-stage breast cancer who are receiving chemotherapy, shortening the time between treatment cycles or administering the agents sequentially may reduce disease recurrence and mortality compared with standard chemotherapy regimens.
Learning to accept the physical changes breast cancer creates is often difficult, but doable. It takes time to learn to embrace change but doing so is beneficial to well being.
During cancer treatment, patients lose a lot of things, but one thing that’s constantly noticed is hair loss.
Treatment options for patients with HER2-positive breast cancer continue to expand, especially after the Food and Drug Administration (FDA) approval of Nerlynx (neratinib) earlier in 2017 and the more recent priority review designation of Perjeta (pertuzumab).
Breast cancer survivor shares her journey after testing positive for a newly discovered genetic mutation (PALB2) related to breast cancer.
Treatment for metastatic cancer can mean asking a tough question every single day.
This cancer survivor learned how mindfulness can change the way we heal.
How to survive your own breast cancer survival surprise party.
Silicone doesn't last forever. After a few years of constant wear, a prosthesis breaks down and is no longer functional. Some women become very attached to their replacement breasts and find it difficult to say goodbye. This is one survivor's light hearted look at what to do with worn out breast forms.
Not for the faint of heart, cancer challenges every aspect of our lives.
Practicing gratitude is an art. But how do we learn to give thanks for the difficult things, like breast cancer? One survivor shares her experience.
